Eris Lifesciences Completes Acquisition of Velbiom Probiotics’ Business
Eris Lifesciences Limited announced the completion of its acquisition of the probiotics business of Velbiom Probiotics Private Limited. The transaction achieved closure on March 31, 2026, following an initial notification provided on March 20, 2026. The acquisition details were previously outlined in the earlier notification. Milind Talegaonkar, Company Secretary & Compliance Officer, confirmed the completion.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.